For specific anticipated scenarios with advice to unblind, read this guidance on unblinding clinical scenarios.
Any pregnant participant must stop trial treatment in the event of pregnancy. Unblinding procedures should be initiated as it may implicate how pregnancy is managed. Unless the participant wishes to terminate the pregnancy for other reasons
Unblinding in the case of pregnancy can be completed by the PI but must not be completed by the blinded rater.